New York City Mayor Zohran Mamdani announced Friday a $15 million allocation over the next two fiscal years to expand access to "gender-affirming" healthcare. The initiative is presented as a direct response to federal actions aimed at restricting gender-transition treatments, particularly for minors, and seeks to ensure continued access to care for transgender residents within the city.
"While the federal government attacks trans New Yorkers and threatens the providers who care for them, our administration is stepping up." — Zohran Mamdani, New York City Mayor
The funding package outlined by Mayor Mamdani includes several key components designed to bolster healthcare access. These include subsidies for healthcare providers, the establishment of a direct care access fund, and the creation of a dedicated transgender call and text hotline. Additionally, the investment will support research into LGBTQ+ healthcare access and fund a pilot program at a clinic located in Queens. City officials emphasized that the initiative's primary goal is to safeguard transgender residents' access to necessary healthcare despite increasing scrutiny from the federal government.
Mayor Mamdani stated the city's commitment to defending transgender patients and medical professionals, specifically referencing ongoing investigations by the Trump administration into providers offering gender-transition treatments for minors. "While the federal government attacks trans New Yorkers and threatens the providers who care for them, our administration is stepping up," Mamdani said in a statement. He added, "We will do everything in our power to defend the rights, safety and dignity of transgender New Yorkers and ensure they continue to receive the healthcare they need." The Mayor has also instructed the city’s Law Department to prepare for potential legal challenges should the federal government attempt to restrict or block access to gender-affirming care within New York City. Deputy Mayor for Economic Justice Julie Su echoed these sentiments, criticizing federal policies as "not just cruel, it's dangerous." Taylor Brown, director of the Mayor’s Office of LGBTQIA+ Affairs, commented that the administration's actions are driven by politics rather than science.
This announcement from New York City comes amidst intensified federal scrutiny and action regarding gender-transition treatments. The Justice Department continues its investigations into medical providers involved in such treatments for minors. Last year, federal authorities issued subpoenas to over 20 doctors and clinics as part of inquiries into potential healthcare fraud, false statements, and related offenses. Former Attorney General Pamela Bondi had previously indicated that medical professionals providing gender-transition treatments for children would face accountability under federal law, and she directed investigations into the marketing of puberty blockers, cross-sex hormones, and other medications used in pediatric gender-transition care.
Shortly after returning to office, President Donald Trump signed an executive order prohibiting federal funding or support for gender-transition procedures for minors. The order also mandated federal agencies to enforce existing laws restricting such treatments for children. The legal landscape surrounding gender-affirming care has seen significant developments, including a U.S. Supreme Court ruling in 2025 that upheld Tennessee’s restrictions on puberty blockers, cross-sex hormones, and certain gender-transition treatments for minors.
New York City has also engaged in its own legal challenges against federal efforts. The city previously contested federal attempts to obtain medical records from transgender healthcare providers. Earlier this month, a federal judge issued a temporary block, preventing the Justice Department from accessing patient records while litigation remains ongoing.
The debate over gender-affirming care involves complex considerations. Supporters argue that these treatments, when administered under established clinical guidelines to carefully evaluated patients diagnosed with gender dysphoria, can effectively reduce distress. They emphasize that such care is often medically necessary. Conversely, critics raise concerns about the potential for significant and irreversible health risks associated with these interventions, particularly for minors. They also question the long-term evidence supporting the efficacy and safety of such treatments in pediatric populations.
While city officials described the $15 million initiative as an initial investment, some progressive lawmakers have argued that the funding falls short of actual needs. Councilmember Tiffany Cabán, for instance, advocated for a substantially larger allocation, suggesting approximately $60 million, to provide more comprehensive support for transgender youth. Budget Director Sherif Soliman acknowledged the current allocation as "a start" and expressed optimism that additional funding could be secured as the city's financial situation permits. The city's actions underscore a growing divergence between state and federal approaches to healthcare policy concerning transgender individuals.
